Coca-Cola HBC (LON:CCH) pulls back from 2026 high on Egypt finance pressures

Coca-Cola HBC (LON:CCH) pulls back from 2026 high on Egypt finance pressures

July 7, 2026

LONDON, July 6, 2026, 23:03 BST

  • Coca-Cola HBC lost 2.8% to 5,025p, making it the third-worst performer on the FTSE 100 on Monday.
  • The shares finished 2.1% higher than where they closed on June 30, after reaching a year high at 5,195p.
  • Emerging markets are expected to account for 55% of FY26 comparable EBIT. That puts a spotlight on Tuesday’s event in Egypt.

Coca-Cola HBC AG (LON:CCH) dropped 145p, down 2.81% at 5,025p on Monday. That was the third-biggest faller on the FTSE 100 after Compass Group and Associated British Foods. The FTSE 100 index slipped 0.26% to end at 10,651.77.

CCH didn’t snap its rally on the drop. Shares climbed 5.1% from June 30 to July 3, reached 5,195p on Monday, and closed up 2.1% from June 30. Trading volume was 527,780 shares, up from 326,410 on Friday.

The main thing now is Egypt. It’s not about another UK consumer data point. Coca-Cola HBC has a July 7 Bitesize event on its calendar focused on Egypt, featuring COO Naya Kalogeraki and the Egypt team, plus a Q&A with CEO Zoran Bogdanovic and the CFO.

Fresh headlines out of Egypt set a firmer tone at the meeting. Ahram Online reported Coca-Cola HBC has opened a digital center in Cairo aimed at 27 markets, starting with 250 hires and planning to hit 450 by 2027. Egypt’s annual digital exports are projected to see a $34 million boost from the move. Amwal Al Ghad, quoting Egypt’s Cabinet, said the company plans an extra $1.28 billion investment in the country by 2030, on top of more than $1.1 billion it is spending from 2022 to 2025. Mourad Ajarti, chief digital transformation and technology officer for the group, said Egypt was chosen for its “qualified workforce” and “advanced technological infrastructure.” Ahram Online

This matters to investors because Egypt is part of Emerging markets, the group’s best-performing large segment. In Q1, Emerging markets’ organic revenue went up 15.0%, topping the group’s 11.6%. The segment accounted for 455.9 million out of 706.0 million unit cases and brought in 1.326 billion euros of the group’s 2.710 billion euros net sales revenue. Bogdanovic said Q1 was “a good start to the year” and left 2026 guidance unchanged. Investegate

Vuma’s public consensus, last updated April 16, gives the segment’s numbers. These are from public consensus, not company guidance.

FY26 forecastNet sales revenueShare of groupComparable EBITShare of group
Established markets€3.70 bln30.0%€397 mln26.9%
Developing markets€2.69 bln21.8%€261 mln17.7%
Emerging markets€5.93 bln48.2%€816 mln55.4%
Total group€12.32 bln100.0%€1.47 bln100.0%

The finance cost forecast is where things changed. Back in May, Coca-Cola HBC said it used bond issuance for the 1.4 billion euro payment in the Coca-Cola Beverages Africa deal, bumping up its 2026 net finance cost view to 45 million to 65 million euros, previously 25 million to 45 million euros. The public consensus, not updated after the guidance, still has FY26 net finance costs at 29 million euros.

MeasureCompany 2026 guidance/actionPublic consensus FY26Public consensus FY27
Organic revenue growth6%-7%6.3%6.3%
Organic comparable EBIT growth7%-10%9.2%8.6%
Net finance costs€45 mln-€65 mln€29 mln€46 mln
Comparable EPS€2.90€3.18
Free cash flow€711 mln€776 mln

The African transaction brings the biggest change to earnings. Coca-Cola Company and Gutsche Family Investments have agreed to sell a 75% controlling stake in Coca-Cola Beverages Africa to Coca-Cola HBC, valuing the unit at $3.4 billion. The deal is set to close by end-2026. Coca-Cola HBC can also buy the last 25% from Coca-Cola within six years.

The company will next report 2026 half-year numbers on Aug. 5. But first comes the Egypt presentation on Tuesday, which will focus on local volumes, pack mix, and updates on digital sales tools.

Konrad Wysocki

Konrad Wysocki is a senior markets reporter at Bez-kabli.pl, specializing in technology stocks, artificial intelligence and global financial markets. A graduate of the University of Rzeszów, he previously worked in investment research and market analysis. His coverage helps readers understand the key trends, companies and innovations influencing investors worldwide.

Stock Market Today

  • Prescient Therapeutics (ASX:PTX) trims cash burn, but runway stays tight
    July 6, 2026, 6:26 PM EDT. Prescient Therapeutics (ASX:PTX) reported AU$9.8 million in cash and no debt at December 2025. The company is burning about AU$8.0 million a year, giving it a 15-month runway on current spending. Revenue came in at AU$4.3 million, but the business is still in the development phase and not generating real operating income. Spending on development dropped 18% over the year. Losses continue, so investors may see dilution or debt if the company looks to raise more funds. Cash burn is heading down, but management will have to watch the balance closely as the cash runway shrinks.